Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy
Publication type: Journal Article
Publication date: 2023-08-01
scimago Q1
wos Q1
SJR: 1.197
CiteScore: 8.4
Impact factor: 4.7
ISSN: 00142999, 18790712
PubMed ID:
37269974
Pharmacology
Abstract
Lipid signaling is defined as any biological signaling action in which a lipid messenger binds to a protein target, converting its effects to specific cellular responses. In this complex biological pathway, the family of phosphoinositide 3-kinase (PI3K) represents a pivotal role and affects many aspects of cellular biology from cell survival, proliferation, and migration to endocytosis, intracellular trafficking, metabolism, and autophagy. While yeasts have a single isoform of phosphoinositide 3-kinase (PI3K), mammals possess eight PI3K types divided into three classes. The class I PI3Ks have set the stage to widen research interest in the field of cancer biology. The aberrant activation of class I PI3Ks has been identified in 30–50% of human tumors, and activating mutations in PIK3CA is one of the most frequent oncogenes in human cancer. In addition to indirect participation in cell signaling, class II and III PI3Ks primarily regulate vesicle trafficking. Class III PI3Ks are also responsible for autophagosome formation and autophagy flux. The current review aims to discuss the original data obtained from international research laboratories on the latest discoveries regarding PI3Ks-mediated cell biological processes. Also, we unravel the mechanisms by which pools of the same phosphoinositides (PIs) derived from different PI3K types act differently.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Current Issues in Molecular Biology
3 publications, 8.82%
|
|
|
International Journal of Molecular Sciences
2 publications, 5.88%
|
|
|
Drug Discovery Today
2 publications, 5.88%
|
|
|
ACS Medicinal Chemistry Letters
1 publication, 2.94%
|
|
|
British Journal of Haematology
1 publication, 2.94%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 2.94%
|
|
|
Cell Biochemistry and Function
1 publication, 2.94%
|
|
|
Pathology Research and Practice
1 publication, 2.94%
|
|
|
mBio
1 publication, 2.94%
|
|
|
Cell Reports
1 publication, 2.94%
|
|
|
Pharmacological Research
1 publication, 2.94%
|
|
|
Cellular and Molecular Life Sciences
1 publication, 2.94%
|
|
|
Frontiers in Immunology
1 publication, 2.94%
|
|
|
Frontiers in Oncology
1 publication, 2.94%
|
|
|
PLoS ONE
1 publication, 2.94%
|
|
|
Journal of Xenobiotics
1 publication, 2.94%
|
|
|
Archives of Virology
1 publication, 2.94%
|
|
|
Journal of Traditional and Complementary Medicine
1 publication, 2.94%
|
|
|
Molecular Neurobiology
1 publication, 2.94%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 2.94%
|
|
|
Pharmaceuticals
1 publication, 2.94%
|
|
|
Journal of Functional Foods
1 publication, 2.94%
|
|
|
Frontiers in Pharmacology
1 publication, 2.94%
|
|
|
Chinese Medicine
1 publication, 2.94%
|
|
|
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
1 publication, 2.94%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 2.94%
|
|
|
ChemistrySelect
1 publication, 2.94%
|
|
|
Journal of Virology
1 publication, 2.94%
|
|
|
Journal of Translational Medicine
1 publication, 2.94%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 publications, 23.53%
|
|
|
MDPI
7 publications, 20.59%
|
|
|
Springer Nature
5 publications, 14.71%
|
|
|
Frontiers Media S.A.
4 publications, 11.76%
|
|
|
Wiley
3 publications, 8.82%
|
|
|
American Society for Microbiology
2 publications, 5.88%
|
|
|
American Chemical Society (ACS)
1 publication, 2.94%
|
|
|
Public Library of Science (PLoS)
1 publication, 2.94%
|
|
|
Taylor & Francis
1 publication, 2.94%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 2.94%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 2.94%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
34
Total citations:
34
Citations from 2024:
30
(88.24%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Safaroghli-Azar A. et al. Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy // European Journal of Pharmacology. 2023. Vol. 953. p. 175827.
GOST all authors (up to 50)
Copy
Safaroghli-Azar A., Sanaei M., Pourbagheri-Sigaroodi A., Bashash D. Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy // European Journal of Pharmacology. 2023. Vol. 953. p. 175827.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.ejphar.2023.175827
UR - https://doi.org/10.1016/j.ejphar.2023.175827
TI - Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy
T2 - European Journal of Pharmacology
AU - Safaroghli-Azar, Ava
AU - Sanaei, Mohammad‐Javad
AU - Pourbagheri-Sigaroodi, Atieh
AU - Bashash, Davood
PY - 2023
DA - 2023/08/01
PB - Elsevier
SP - 175827
VL - 953
PMID - 37269974
SN - 0014-2999
SN - 1879-0712
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Safaroghli-Azar,
author = {Ava Safaroghli-Azar and Mohammad‐Javad Sanaei and Atieh Pourbagheri-Sigaroodi and Davood Bashash},
title = {Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy},
journal = {European Journal of Pharmacology},
year = {2023},
volume = {953},
publisher = {Elsevier},
month = {aug},
url = {https://doi.org/10.1016/j.ejphar.2023.175827},
pages = {175827},
doi = {10.1016/j.ejphar.2023.175827}
}